Arsani William, Director at Design Therapeutics (NASDAQ:DSGN), reported a large insider buy on September 6, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that William purchased 700,000 shares of Design Therapeutics. The total transaction amounted to $14,000,000.
Design Therapeutics shares are trading down 4.51% at $2.54 at the time of this writing on Thursday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
The Importance of Insider Transactions
Insider transactions shouldn't be used primarily to make an ...